Abdelmalik Slassi
Directeur/Membre du Conseil chez PHARMALA BIOTECH HOLDINGS INC.
Fortune : 1 M $ au 31/10/2023
Profil
Abdelmalik Slassi was the founder of Mindset Pharma, Inc. (2019) where he held the title of Senior Vice President-Innovation.
He is also the founder of Fluorinov Pharma, Inc. Dr. Slassi's current jobs include being an Independent Director at Pharmala Biotech Holdings, Inc. (2021-present) and a Director at Pharmala Biotech, Inc. (present).
Dr. Slassi's former jobs include being a Director & Vice President-Medicinal Chemistry at NPS Pharmaceuticals, Inc., a Director & VP-Manufacturing & Drug Development at Cascade Therapeutics, Inc., and Senior Vice President-Drug Discovery Research at Trillium Therapeutics ULC (2016-2019).
Dr. Slassi received a doctorate degree from Université Claude Bernard Lyon 1.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MINDSET PHARMA INC.
1,50% | 31/08/2023 | 1 523 500 ( 1,50% ) | 1 M $ | 31/10/2023 |
| 27/02/2024 | 350 000 ( 0,38% ) | 29 050 $ | 30/06/2024 |
Postes actifs de Abdelmalik Slassi
| Sociétés | Poste | Début |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur/Membre du Conseil | 21/03/2021 |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
Anciens postes connus de Abdelmalik Slassi
| Sociétés | Poste | Fin |
|---|---|---|
| TRILLIUM THERAPEUTICS | Corporate Officer/Principal | 01/12/2019 |
Fluorinov Pharma, Inc.
 Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Fluorinov Pharma, Inc. operates as a Canadian pharmaceutical company. The company is based in Toronto, Canada. The company was founded by Abdelmalik Slassi. | Fondateur | 01/01/2016 |
| MINDSET PHARMA INC. | Fondateur | - |
Cascade Therapeutics, Inc.
 Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cascade Therapeutics, Inc. is an American company that engages in the research of biological products. The private company is based in Potomac. | Directeur/Membre du Conseil | - |
| NPS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - |
Formation de Abdelmalik Slassi
| Université Claude Bernard Lyon 1 | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MINDSET PHARMA INC. | Health Technology |
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Cascade Therapeutics, Inc.
Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cascade Therapeutics, Inc. is an American company that engages in the research of biological products. The private company is based in Potomac. | Commercial Services |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
Fluorinov Pharma, Inc.
Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Fluorinov Pharma, Inc. operates as a Canadian pharmaceutical company. The company is based in Toronto, Canada. The company was founded by Abdelmalik Slassi. | Health Technology |
